PIMCO Municipal Income Opportunities Active ETF MINO 深 沪
等待开盘 11-07 09:30:00 美东时间
45.565
+0.065
+0.14%
华盛通- 最 高45.60
- 今 开45.56
- 成交量 4.38万股
- 最 低 45.55
- 昨 收 45.50
- 总市值 3.29亿
- 52周最高 45.66
- 市盈率 静 --
- 换手率 0.61%
- 52周最低 41.31
- 委 比 50.00%
- 总股本 722.00万
- 历史最高 49.725
- 量 比 0.77
- 振 幅 0.11%
- 历史最低 36.3075
- 每 手 1
- 风险率 0.71%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cardio Diagnostics' PrecisionCHD Test To Detect Hidden Forms Of Heart Disease INOCA And MINOCA, To Be Presented At AHA Sessions
Ischemia with No Obstructive Coronary Arteries (INOCA) and Myocardial Infarction with No Obstructive Coronary Arteries (MINOCA) are two underdiagnosed, potentially fatal forms of heart disease that standard diagnostic testing routinely fails to detect
11-05 21:37
STRATA Skin Sciences Rises 25% Pre-Market — Here's Why
STRATA gained on premarket trading after receiving Mexican regulatory approval for its TheraClearX acne treatment system.
10-29 16:43
Synopsys To Showcase Advancements In Engineering Solutions From Silicon To Systems At NVIDIA GTC Washington, D.C.
Synopsys, Inc. (NASDAQ:SNPS) is attending NVIDIA GTC Washington, D.C. October 27-29 to showcase advancements in engineering solutions from silicon to systems that will underpin the next era of industrial innovation. Now
10-29 02:36
Minovia Therapeutics Receives FDA Fast Track Designation for MNV-201 in Myelodysplastic Syndrome
Minovia Therapeutics Ltd. announced that the U.S. FDA has granted Fast Track Designation to its lead compound, MNV-201, for the treatment of Myelodysplastic Syndrome (MDS), a serious age-related hematologic disease. MNV-201, a first-in-class mitochondrial cell therapy, is already under investigation for Pearson Syndrome and aims to address unmet medical needs in mitochondrial diseases. The designation facilitates faster development and review, po...
09-18 11:30
Somnigroup International's CorMedix to Acquire Melinta in $300M Deal, Expanding Infectious Disease Portfolio
CorMedix Inc. ("CorMedix") (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, and Melinta Therapeutics LLC ("Melinta"),
08-07 19:14
Ulike Air 10 Review: Why Beauty Experts Are Calling It a Game-Changer
Ulike Air 10 IPL Hair Removal Device is making waves in the at-home beauty tech market—and for good reason.
06-01 04:21
FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases
FDA grants accelerated approval to AbbVie's Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes $335 million upfront.
05-15 03:25
Suminoe Textile Announces Name Change and Releases Integrated Report 2024
Suminoe Textile Co., Ltd. ( ($JP:3501) ) has issued an announcement. Suminoe Te...
03-19 23:52
AbbVie submits BLA for antibody-drug conjugate Teliso-V for NSCLC
AbbVie (NYSE:ABBV) has submitted an NDA to the U.S. FDA for its antibody-drug conjugate telisotuzumab vedotin (Teliso-V) for previously treated non-small cell lung cancer. Specifically, the applicatio...
2024-09-28 00:42
